Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers - Wikidata - awgldk - TriplyDB

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

http://www.wikidata.org/entity/Q21195201

about

MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids Circulating microRNAs: potential biomarkers for common malignancies Minireview: miRomics in endocrinology: a novel approach for modeling endocrine diseases.MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.Alterations in circulating miRNA levels following early-stage estrogen receptor-positive breast cancer resection in post-menopausal women.Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.Circulating miR-148b and miR-133a as biomarkers for breast cancer detection.Plasma miRNAs as potential biomarkers of chronic degenerative valvular disease in Dachshunds.Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Dampening enthusiasm for circulating microRNA in breast cancer.Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.Plasma microRNA panel for minimally invasive detection of breast cancer Regulation of cancer metastasis by cell-free miRNAs.Influence of plasma processing on recovery and analysis of circulating nucleic acids.Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.miRNA - Therapeutic tool in breast cancer? Where are we now?Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.Analysis of miRNA expression profiles in breast cancer using biclustering.Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer.The Roles of MicroRNAs in Breast Cancer The effects of low-level laser irradiation on breast tumor in mice and the expression of Let-7a, miR-155, miR-21, miR125, and miR376b.A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.Controlled ovarian hyperstimulation induced changes in the expression of circulatory miRNA in bovine follicular fluid and blood plasma.MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.Prediction of miRNA-disease associations with a vector space model Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.Plasma exosome microRNAs are indicative of breast cancer.MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway.High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.Targeting MicroRNAs in Cancer Gene Therapy.

P2860

Q26775086-20213347-5C1C-48F4-9790-0B6B88BD14A6 Q26825022-2CD1A3CB-EB51-4098-A933-1CD6816DD559 Q28081347-2E88AFF5-7E4A-4215-A2F6-6507D1228CC2 Q33635886-67632862-903A-4256-8B61-7D6485F01CEE Q33823829-F7A0566D-6AE0-40BC-A37B-1C23314C365E Q33864278-F86BCE16-04E8-4F5E-86C1-F8C02E5643FF Q33916362-33209D93-6D7C-4EA3-977B-2A5E288D004F Q34221705-E859DBFD-048C-479C-AAD1-10317A2A9AFF Q34324137-26772C5C-4419-4A0C-BB5C-16F12BD57AF5 Q34426839-EC094FCB-472A-4CFD-A803-B07B87F800E0 Q34599354-EA19CEC0-F8D6-4370-81E8-640C1927E77E Q34614489-7ED140AE-2FEB-4E8E-9FCF-26A164DF72D9 Q34654554-9608EB8E-B3F2-4EA4-945F-072235F89884 Q35009302-5EFC92C6-941B-4B06-86B3-DB2DA95A5110 Q35032320-25E559E0-C089-4D04-8B45-374C64500543 Q35034340-615E5096-6420-4CEB-8E6B-2AB03CC0D3DC Q35035846-33165C6F-5482-4BBF-8C85-8BB0A4BE1B82 Q35055089-33D14651-C2A8-4082-ACD0-F0567B720CE6 Q35082591-DC264EE5-FE78-4651-A20C-7BC42FD0E532 Q35094742-98766749-DAE2-4FB2-9AB1-4DB527138DEE Q35113386-1212FBF7-DCA5-48CF-8094-43643CB2E732 Q35120108-0B21F82B-B255-41D5-BC8C-9CF37135FA34 Q35123674-74782E16-59FE-47EA-948B-1F59869FAFB1 Q35141171-EABFD3F7-EAB3-4A09-86E6-154FFAA14E73 Q35203556-2E03D96E-5807-408D-81AF-FCDBFDC7A7C8 Q35543094-B1EE986D-7CE1-4551-93C7-93ECD781F79D Q35786673-970C7128-49E1-4FED-8EA7-DFD331D024E4 Q35818407-437A0D95-498A-472E-948B-5A3F0D335ECF Q36102632-5A6843D1-2C65-463E-B289-F8AE071D6530 Q36212307-2D7CEFFC-88FF-4B36-BF4A-C322A36C0117 Q36357957-550DCFAF-962C-4680-9D0E-4D3350025E65 Q36727107-9DF2FD89-9E8D-4105-AE7A-C5A7E0D35390 Q36829811-6006C12E-09C4-4CB2-8270-94556E77A352 Q36939358-AAE350EF-4072-4B38-AE5F-74102E46C768 Q36953740-E32A7CDF-72A6-489B-A58A-460F410E5A55 Q36997902-4F89AB91-314C-4C75-852E-07D5C2401DFC Q37243591-AA9EE793-82C2-4A90-8E4C-B1A8CC172BFF Q37317467-55B4943F-1A15-46E0-9E67-CD97AE1E9F1C Q37451898-4ED53C97-2D1E-4683-B6DA-2E3F51F031BC Q37628264-5D0EFB0B-BD91-4D83-BC70-D49846CC201E

P2860

Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers

http://www.wikidata.org/entity/Q21195201

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Expression profiling of cancer ...... cancer and healthy volunteers

@ast

Expression profiling of cancer ...... cancer and healthy volunteers

@en

Expression profiling of cancer ...... cancer and healthy volunteers

@en-gb

Expression profiling of cancer ...... cancer and healthy volunteers

@nl

type

label

Expression profiling of cancer ...... cancer and healthy volunteers

@ast

Expression profiling of cancer ...... cancer and healthy volunteers

@en

Expression profiling of cancer ...... cancer and healthy volunteers

@en-gb

Expression profiling of cancer ...... cancer and healthy volunteers

@nl

prefLabel

Expression profiling of cancer ...... cancer and healthy volunteers

@ast

Expression profiling of cancer ...... cancer and healthy volunteers

@en

Expression profiling of cancer ...... cancer and healthy volunteers

@en-gb

Expression profiling of cancer ...... cancer and healthy volunteers

@nl

P1433

Q21195201-B2B0D895-B68A-4CC9-8C48-379240C8A8A7

P1476

Q21195201-17A05F49-965B-415F-A2BA-931CD86ABE58

P2093

Q21195201-10228CF4-433F-4B39-AF1A-5E3119435ADF

Q21195201-4A5F5EF8-DD8A-48AE-A579-76FED7B36912

Q21195201-59DD632C-4156-4F7D-B0D8-3DBDE0A3E272

Q21195201-69317EFB-E6C3-4D6E-B3F3-B25F5BDE115E

Q21195201-7636BBB5-3D9D-4AE3-BB16-09208AA7D093

Q21195201-9043951C-6CBC-4867-8D04-78C0E3D6CD1C

Q21195201-9E6EE71E-0C40-4072-A82E-872AEB1E7113

Q21195201-BEBF4179-2C20-4AC9-970F-20EFD1091EDB

Q21195201-D136062A-CB64-48AB-B80D-A5FF33A61611

P2860

Q21195201-033FFC3B-014A-449A-BAA0-130F52F62BBC

Q21195201-06772C2A-15D7-42B2-AA67-91E3977B0C40

Q21195201-14C5C0F9-2334-4070-B336-C71ED94C0D4A

Q21195201-14ED7910-F93B-46FF-B4EE-A7C9F4867334

Q21195201-1EF13F1B-E5D3-408D-AC2E-FF828209CC3B

Q21195201-2B4A9463-E891-4219-BFEF-5E28A23DF00D

Q21195201-2C23A13B-DEC5-4749-9280-B7B64817316A

Q21195201-2F5EFF04-1929-4554-BA43-0B98BFE4C9FF

Q21195201-304742A1-F5CE-4955-AD1C-CAADA2170029

Q21195201-39CC7174-2AB9-4B11-877E-734A687A22FF

P2888

Q21195201-6F6A37F9-2006-49E4-89AF-A18DCEDF1285

P304

Q21195201-E6194894-009B-4EE2-BE5C-DB83987E9D21

P31

Q21195201-A28040B7-1576-4DDB-84F4-4DD87AB7F200

P3181

Q21195201-17D39521-2F8E-4B3B-8F58-8C292F7185DC

P356

Q21195201-3F8BE217-4CE1-4604-9D08-952843344F07

P407

Q21195201-1F020E66-D286-4938-BACB-F2EDD2326B26

P433

Q21195201-890593BC-8D90-4DD7-8752-7A4D8F8FC996

P478

Q21195201-C91F95CB-2874-4914-9DC9-963666DBA08A

P50

Q21195201-09329273-F35A-4E91-8D37-8C1864328FB5

P577

Q21195201-4DD9EEE7-BD8C-4BCA-9D35-C8BA35F603F4

P5875

Q21195201-888C6D54-C7F4-40C5-B81A-342B6BF9DFBC

P6179

Q21195201-D01EE04A-DC1C-4453-ABD4-437548D474C4

P698

Q21195201-9B4E9C13-B567-4B23-9B73-6C9ECE2C1AEA

P921

Q21195201-0BBBAAAA-36EC-4566-99CA-DE0D75B9305D

Q21195201-166242FB-3937-40C9-AEFD-185112E308D0

P932

Q21195201-D839BE32-5832-473D-81EB-C19C2490D358

P3181

P356

P1433

Breast Cancer Research

P1476

Expression profiling of cancer ...... cancer and healthy volunteers

@en

P2093

Dieter J Peeters

http://www.w3.org/2001/XMLSchema#string

Eleni van Schooneveld

http://www.w3.org/2001/XMLSchema#string

Hans Wildiers

http://www.w3.org/2001/XMLSchema#string

Ilse Van der Auwera

http://www.w3.org/2001/XMLSchema#string

Luc Y Dirix

http://www.w3.org/2001/XMLSchema#string

Maartje Ca Wouters

http://www.w3.org/2001/XMLSchema#string

Peter A Van Dam

http://www.w3.org/2001/XMLSchema#string

Peter B Vermeulen

http://www.w3.org/2001/XMLSchema#string

Steven J Van Laere

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of microRNA expression in human peripheral blood microvesicles

Serum microRNAs are promising novel biomarkers

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer

Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5

A microRNA expression signature of human solid tumors defines cancer gene targets

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Microvesicles: mediators of extracellular communication during cancer progression

MicroRNAs in NF-kappaB signaling

MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

Circulating microRNAs as stable blood-based markers for cancer detection.

P2888

P304

R34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1146935

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/BCR3127

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221850669

http://www.w3.org/2001/XMLSchema#string

P6179

1049102770

http://www.w3.org/2001/XMLSchema#string

P698

22353773

http://www.w3.org/2001/XMLSchema#string

P921

P932

3496152

http://www.w3.org/2001/XMLSchema#string